Treatment for inclusion body myositis

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2007, Pages

  Rose, Michael R ^a   Dalakas, M ^b   Griggs, R ^b   Leong, K ^b   Miller, J ^b   Walter, M C ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANABOLIC AGENT; ANTIOXIDANT; AZATHIOPRINE; CARNITINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; PREDNISONE; UBIQUINONE;

CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; INCLUSION BODY MYOSITIS; KINESIOTHERAPY; LEUKAPHERESIS; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PLASMAPHERESIS; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; TENDON TRANSFER; WEAKNESS;

EID: 44949263037     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001555.pub2     Document Type: Review

References (13)

1. Argov 1984 Argov Z, Yarom R. "Rimmed vacuolemyopathy" sparing the quadriceps. A unique disorder in Iranian Jews. Journal of Neurological Sciences 1984;64(1):33-43. [MEDLINE: 1984241874].
2. Carpenter 1978 Carpenter S, Karpati G, Heller I, Eisen A. Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology 1978;28(1):8-17. [MEDLINE: 1978072119].
3. Cole 1988 Cole AJ, Kuzniecky R, Karpati G, Carpenter S, Andermann E, Andermann F. Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy - a new syndrome. Brain 1988;111(Part 5):1025-37. [MEDLINE: 1989027587].
4. Griggs 1995 Griggs RC, Askanas V, DiMauro S, Engel AG, Karpati G, Mendell JR, et al.Inclusion body myositis and myopathies. Annals of Neurology 1995;38(5):705-13. [MEDLINE: 1996074181].
5. Griggs 1998 Griggs RC, Rose MR. Evaluation of treatment for sporadic inclusion body myositis. In: AskanasV, SerratriceG, EngelWK editor(s). Inclusion body myositis and myopathies. Cambridge University Press, 1998:331-50.
6. Hill 2004 Hill M, Hughes T, Milford C. Treatment for swallowing difficulties (dysphagia) in chronic muscle disease. Cochrane Database of Systematic Reviews 2004, Issue 2.Art. No.: CD004303. DOI: 10.1002/14651858.CD004303.pub2.
7. Kalimo 1988 Kalimo H, Savontaus ML, Lang H, Paljarvi L, Sonninen V, Dean PB, et al.X-linked myopathy with excessive autophagy: a new hereditary muscle disease. Annals of Neurology 1988;23(3):258-65. [MEDLINE: 1988239496].
8. Lotz 1989 Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis. Observations in 40 patients. Brain 1989;112(Part 3):727-47. [MEDLINE: 1989274771].
9. Neville 1992 Neville HE, Baumbach LL, Ringel SP, Russo LS Jr, Sujansky E, Garcia CA. Familial inclusion body myositis: evidence for autosomal dominant inheritance [see comments]. Neurology 1992;42(4):897-902. [MEDLINE: 1992228190].
10. Rose 2001 Rose MR, McDermott MP, Thornton CA, Palenski C, Griggs RC. A prospective longitudinal natural history study of inclusion body myositis; implications for clinical trials. Neurology 2001;57(3):548-50. [MEDLINE: 2609].
11. Rugiero 1995 Rugiero M, Koffman B, Dalakas MC. Association of inclusion body myositis with autoimmune diseases and autoantibodies [Abstract]. Annals of Neurology 1995;38(2):333.
12. Van der Kooi 2005 van der Kooi EL, Lindeman E, Riphagen I. Strength training and aerobic exercise training for muscle disease. Cochrane Database of Systematic Reviews 2005, Issue 1.Art. No.: CD003907. DOI: 10.1002/14651858.CD003907.pub2.
13. Ware 1992 Ware JE, Sherbourne CD. The MOS 36 item short form survey (SF 36): conceptual framework and item selection. Medical Care 1992;30(6):473-83.